- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Oligomeric tau-targeted immunotherapy in Tg4510 mice ; volume:9 ; number:1 ; day:27 ; month:6 ; year:2017 ; pages:1-15 ; date:12.2017
Alzheimer's research & therapy ; 9, Heft 1 (27.6.2017), 1-15, 12.2017
- Keyword
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Creator
-
Schroeder, Sulana
- Contributor
-
Joly-Amado, Aurelie
Soliman, Ahlam
Sengupta, Urmi
Kayed, Rakiz
Gordon, Marcia N.
Morgan, David
SpringerLink (Online service)
- DOI
-
10.1186/s13195-017-0274-6
- URN
-
urn:nbn:de:1111-201709224159
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schroeder, Sulana
- Joly-Amado, Aurelie
- Soliman, Ahlam
- Sengupta, Urmi
- Kayed, Rakiz
- Gordon, Marcia N.
- Morgan, David
- SpringerLink (Online service)
Other Objects (12)
Characterization of tau oligomeric seeds in progressive supranuclear palsy
Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
Discovery and characterization of stable and toxic Tau/phospholipid oligomeric complexes
Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau
Tau immunotherapy is associated with glial responses in FTLD-tau
BCMA-targeted immunotherapy for multiple myeloma
Circadian disruption promotes the neurotoxicity of oligomeric alpha-synuclein in mice
Metformin Attenuates Tau Pathology in Tau-Seeded PS19 Mice
Targeted therapy, immunotherapy, and chemotherapy for chordoma
Tag-free semisynthetic tau proteins and novel antibodies targeted against phospho-tau
Targeted Therapy and Immunotherapy for Melanoma in Japan
Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells
Characterization of tau oligomeric seeds in progressive supranuclear palsy
Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
Discovery and characterization of stable and toxic Tau/phospholipid oligomeric complexes
Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau
Tau immunotherapy is associated with glial responses in FTLD-tau
BCMA-targeted immunotherapy for multiple myeloma
Circadian disruption promotes the neurotoxicity of oligomeric alpha-synuclein in mice
Metformin Attenuates Tau Pathology in Tau-Seeded PS19 Mice
Targeted therapy, immunotherapy, and chemotherapy for chordoma
Tag-free semisynthetic tau proteins and novel antibodies targeted against phospho-tau
Targeted Therapy and Immunotherapy for Melanoma in Japan
Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells
Characterization of tau oligomeric seeds in progressive supranuclear palsy
Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
Discovery and characterization of stable and toxic Tau/phospholipid oligomeric complexes
Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau
Tau immunotherapy is associated with glial responses in FTLD-tau
BCMA-targeted immunotherapy for multiple myeloma
Circadian disruption promotes the neurotoxicity of oligomeric alpha-synuclein in mice
Metformin Attenuates Tau Pathology in Tau-Seeded PS19 Mice
Targeted therapy, immunotherapy, and chemotherapy for chordoma
Tag-free semisynthetic tau proteins and novel antibodies targeted against phospho-tau
Targeted Therapy and Immunotherapy for Melanoma in Japan